Research article · 2019
Review articlePublished 2015
Radiation Oncology Strategies for Patients with Poor Pulmonary Function in Non-small Cell Lung Carcinoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung cancer is the leading cause of cancer deaths worldwide. Recently, there is an emerging interest on lung cancer screening which can increase the incidence of lung cancer among the population in the coming. There was 20% reduction in mortality from lung cancer in the National Lung Screening Trial (NLST) with the use of low-dose computed tomography. NLST criteria included people between ages 55-74 years, ≥30 pack-years of smoking or <15 years since cession of smoking. Patients with early stage disease and young age, good performance status and pulmonary function tests are treated with curative intent including either surgery or combined treatment modalities, concurrent chemo-radiation therapy. Treatment of choice for medically inoperable group of patients is definitive radiation therapy (RT). Patients with poor pulmonary function (PF) are considered a contraindication to definitive RT. We discuss the role of RT and importance of dose escalation to achieve improved local control rates among patients with different stages of non-small cell lung carcinoma (NSCLC) with poor PF. Till date, there are no clinical practice guidelines or randomized prospective phase III studies to treat this subset of high-risk patients with RT dose escalation using advanced RT techniques like intensity modulation radiation therapy, volumetric modulated arc therapy (IMRT, VMAT). Also, there is limited evidence on the use of newer chemotherapy regimens with advanced RT techniques for NSCLC patients with poor PF except for retrospective data or phase I/II studies. Different tools to estimate and measure radiation pneumonitis (RP) along with the review of the published data on RP was done. Impact of newer RT techniques along with adaptive RT using mid-course PET scans for RT planning using photons and protons are also addressed.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2016
Osteoblastic Changes During Non-Small Cell Lung Cancer (NSCLC) Treatment: How to Distinguish between Objective Response and Progressive Disease
Research article · 19 Apr 2023
Dosimetric Comparison of SBRT Plans in Cyberknife and Helical Tomotherapy in Non-Small Cell Lung Cancers
Review article · 2015
Influence of Prognostic Factors on Survival in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Combination of Chemoradiotherapy
Research article · 2012
Visual Functions in Locally Advanced Nasopharyngeal Carcinoma Patients after External Beam Radiation
More from this journal
The newest in Nuclear Medicine & Radiation Therapy.
Opinion · 1 Dec 2025
Radiolabeled Antibody Conjugates: Targeting Cancer Resistance
Brief report · 1 Dec 2025
AI: Precision Radionuclide Therapy Dosimetry Advancements
Brief report · 1 Dec 2025
Multi-Isotope Therapy: Powering Precision Nuclear Oncology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNuclear Medicine & Radiation Therapy
- SubjectRadiology & Imaging
- SubjectEnergy & Power
- BylineArticles whose byline prints “Aruna Turaka”

